Skip to main content
Research

Publications: Dr Radha Gadhok

Ahmad OF, Ayubi H, Clough J, Dart R, Gadhok R, Pannick S, Parkes G, Pavlidis P et al. ( 2021 ) . Quality of care in adult patients with inflammatory bowel disease transferring between healthcare providers: multicentre audit . Frontline Gastroenterology vol. 12 , ( 1 ) 5 - 10 .
Gadhok R, Gordon H, Sebepos-Rogers G, Baillie S, Akbar S, Abbott JE, Michael E, Ahmad OF et al. ( 2020 ) . UK Patients of Bangladeshi Descent with Crohn’s Disease Respond Less Well to TNF Antagonists Than Caucasian Patients . Digestive Diseases and Sciences vol. 65 , ( 6 ) 1790 - 1799 .
Gadhok R, Fragkos K, Honap S, Hassan J, Whiteley L, Ibarra A, Burgess N, Vega R et al. ( 2020 ) . P507 Ustekinumab: Medium-term outcomes from a UK multicentre real-world cohort . Journal of Crohn's and Colitis vol. 14 , ( Supplement_1 ) s439 - s440 .
Gadhok R, Fragkos K, Honap S, Hassan J, Whiteley L, Ibarra A, Burgess N, Vega R et al. ( 2020 ) . Ustekinumab: Medium-term outcomes from a UK multicentre real-world cohort . JOURNAL OF CROHNS & COLITIS . vol. 14 , S439 - S440 .
Rao R, Gadhok R, Whitley L, Ibarra A, Evans J, La Lee H, Kok K, McCartney S ( 2019 ) . ATH-10 Vedolizumab for refractory Crohn’s disease (CD) in adolescents: experience from two UK IBD centres . Gut . Conference: Abstracts of Distinction vol. 68 ,
Gadhok R, Rao R, Honap S, Samaan M, Harpham-Lockyer L, Kwok H, Whitley L, Ibarra A et al. ( 2019 ) . PTH-084 Ustekinumab: Early experience and medium-term outcomes from a UK multi-centre real-world cohort . Gut . Conference: Posters vol. 68 ,
Gadhok R, Rao R, Harpham-Lockyer L, Kwok H, Whitley L, Ibarra A, Burgess N, McCartney S et al. ( 2019 ) . PTH-085 Ustekinumab for refractory Crohn’s disease (CD) in adolescents: experience from two UK IBD centres . Gut . Conference: Posters vol. 68 ,
Honap S, Gadhok R, Rao R, Samaan MA, Harpham-Lockyer L, Kwok H, Whitley L, Ibarra A et al. ( 2019 ) . USTEKINUMAB: EARLY EXPERIENCE AND MEDIUM-TERM OUTCOMES FROM A UK MULTI-CENTRE REAL-WORLD COHORT . GASTROENTEROLOGY . vol. 156 , S885 - S886 .
Gadhok R, Rao R, Honap S, Samaan M, Harpham-Lockyer L, Kwok H, Whitley L, Ibarra A et al. ( 2019 ) . P318 Ustekinumab: early experience and medium-term outcomes from a UK multi-centre real-world cohort . Journal of Crohn's and Colitis . vol. 13 , s260 - s260 .
Rao R, Gadhok R, Whitley L, Burgess N, Amon P, Naik S, Lindsay J, McCartney S et al. ( 2019 ) . P616 Ustekinumab for refractory paediatric Crohn’s disease: experience from two UK tertiary referral centres . Journal of Crohn's and Colitis . vol. 13 , s424 - s425 .
Sebepos-Rogers G, Jayasooriya N, Gadhok R, Gordon H, O’Donnell S ( 2018 ) . PWE-050 Anti-drug antibodies to anti-TNFS: experience and outcomes at a tertiary IBD centre . Gut . Conference: IBD vol. 67 ,
Gordon H, Gadhok R, Ibarra A, Lindsay JO ( 2018 ) . UK Asians are prescribed vedolizumab earlier in disease history than Caucasians, but respond equally well to therapy . JOURNAL OF CROHNS & COLITIS . vol. 12 , S459 - S459 .
Gadhok R, Gordon H, Sebepos-Rogers G, Baillie S, Akbar S, Ahmad OF, Cooper B, Lindsay JO ( 2017 ) . ANTI-TNFS MORE FREQUENTLY STOPPED DUE TO LOSS OF RESPONSE IN BRITISH ASIANS WITH CROHN'S DISEASE: A SINGLE CENTRE RETROSPECTIVE ANALYSIS . GUT . vol. 66 , A255 - A255 .
Gordon H, Gadhok R, Sebepos-Rogers G, Baillie S, Akbar S, Ahmad OF, Cooper BE, Lindsay JO ( 2017 ) . Sa1833 Anti-TNFS More Frequently Stopped Due to Loss of Response in British Asians with Crohn's Disease: A Single Centre Retrospective Analysis . Gastroenterology . vol. 152 ,
Gadhok R, Gordon H, Sebepos-Rogers G, Baillie S, Akbar S, Ahmad OF, Cooper B, Lindsay JO ( 2017 ) . Anti-TNFs more frequently stopped due to loss of response in British Asians with Crohn's disease: a single centre retrospective analysis . JOURNAL OF CROHNS & COLITIS . vol. 11 , S393 - S393 .
Gadhok R, Gordon H, Sebepos-Rogers G, Baillie S, Akbar S, Ahmad OF, Cooper B, Lindsay JO ( 2017 ) . P614 Anti-TNFs more frequently stopped due to loss of response in British Asians with Crohn's disease: a single centre retrospective analysis . Journal of Crohn's and Colitis vol. 11 , ( suppl_1 ) s393 - s393 .
Gadhok R, Murray S, Wood E ( 2016 ) . PTH-126 Virtual Reality and Beyond: Integrating Simulation into The Gastroenterology Training Curriculum . Gut . vol. 65 ,
Hall H, Gadhok R, Alshafi K, Bilton D, Simmonds NJ ( 2015 ) . Eradication of respiratory tract MRSA at a large adult cystic fibrosis centre . Respiratory Medicine vol. 109 , ( 3 ) 357 - 363 .
Green H, Gadhok R, Alshafi K, Bilton D, Simmonds N ( 2013 ) . P100 Successful eradication of respiratory tract MRSA in cystic fibrosis: a retrospective study . Thorax . vol. 68 , a120 - a120 .
Green H, Gadhok R, Alshafi K, Bilton D, Simmonds N ( 2013 ) . A RETROSPECTIVE STUDY OF RESPIRATORY TRACT MRSA ERADICATION AT A LARGE ADULT CYSTIC FIBROSIS UNIT . PEDIATRIC PULMONOLOGY . vol. 48 , 320 - 320 .
Possamai L, McPhail M, Quaglia A, Abeles R, Tidswell R, Gadhok R, Khamri W, Zingarelli V et al. ( 2013 ) . 1008 CHARACTER AND TEMPORAL EVOLUTION OF APOPTOSIS IN ACETAMINOPHEN-INDUCED ACUTE LIVER FAILURE . Journal of Hepatology . vol. 58 , s415 - s416 .
Antoniades C, Triantafyllou E, Gadhok R, Abeles R, Quaglia A, Khamri W, Tidswell R, McPhail M et al. ( 2013 ) . 1013 CD163 IS A MECHANISTIC BIOMARKER IN ACUTE LIVER FAILURE REFLECTING A MACROPHAGE ACTIVATION LIKE SYNDROME . Journal of Hepatology . vol. 58 ,
Tidswell R, Gadhok R, Vergis N, McPhail MJ, Selvapatt N, Vijay GKM, Quaglia A, Bernal W et al. ( 2013 ) . 607 DEFECTIVE MONOCYTE PHAGOCYTOSIS MAY EXPLAIN SUSCEPTIBILITY TO SEPSIS AND BE A TARGET FOR IMMUNOTHERAPY IN ACUTE-ON-CHRONIC LIVER FAILURE . Journal of Hepatology . vol. 58 ,
Russell GK, Gadhok R, Simmonds NJ ( 2013 ) . The destructive combination of Scediosporium apiosperum lung disease and exuberant inflammation in cystic fibrosis . Paediatric Respiratory Reviews vol. 14 , ( SUPPL.1 ) 22 - 25 .
Dickson J, Gadhok R, Hind, Simonds A, Polkey M ( 2012 ) . P231 CPR and Ventilation Preferences in COPD Patients Using Home NIV: Still Unexplored After Ten Years . Thorax . vol. 67 ,
Roberts CH, Smith C, Breen R, Gadhok R, Murphy M, Aryee A, Cropley I, Bhagani S et al. ( 2011 ) . Hepatotoxicity in the treatment of tuberculosis using moxifl oxacincontaining regimens . International Journal of Tuberculosis and Lung Disease vol. 15 , ( 9 ) 1275 - 1276 .
Roberts CH, Gadhok R, Breen R, Murphy M, Smith C, Cropley I, Bhagani S, Hopkins S et al. ( 2009 ) . SAFETY OF MOXIFLOXACIN WHEN USED TO TREAT ACTIVE TUBERCULOSIS IN PATIENTS AT RISK OF HEPATOTOXICITY . THORAX . vol. 64 , A123 - A124 .